Horvath Andrea, Dziechciarz Piotr, Szajewska Hania
Medical University of Warsaw, 2nd Department of Paediatrics, 01-184 Warsaw, Dzialdowska 1, Poland.
Pediatrics. 2008 Dec;122(6):e1268-77. doi: 10.1542/peds.2008-1900. Epub 2008 Nov 10.
Currently, thickened feeds are increasingly being used to treat infants with gastroesophageal reflux, driven in large part by the baby food industry. Previous meta-analyses have shown that although thickened formulas do not seem to reduce measurable reflux, they may reduce vomiting. However, because data are limited, there is still uncertainty regarding the use of thickening agents.
Our goal was to systematically evaluate and update data from randomized, controlled trials on the efficacy and safety of thickened feeds for the treatment of gastroesophageal reflux in healthy infants.
The Cochrane Library, Medline, Embase, and CINAHL databases and proceedings of the European and North American pediatric gastroenterology conferences (from 2000) were searched in May 2008; additional references were obtained from reviewed articles. Only randomized, controlled trials that evaluated thickened feeds used in infants for at least several days for the treatment of gastroesophageal reflux were considered for inclusion. Three reviewers independently performed data extraction by using standard data-extraction forms. Discrepancies between reviewers were resolved by discussion between all authors. Only the consensus data were entered.
Fourteen randomized, controlled trials with a parallel or crossover design, some with methodologic limitations, were included. Use of thickened formulas compared with standard formula significantly increased the percentage of infants with no regurgitation, slightly reduced the number of episodes of regurgitation and vomiting per day (assessed jointly or separately), and increased weight gain per day; it had no effect on the reflux index, number of acid gastroesophageal reflux episodes per hour, or number of reflux episodes lasting >5 minutes but significantly reduced the duration of the longest reflux episode of pH<4. No definitive data showed that one particular thickening agent is more effective than another. No serious adverse effects were noted.
This meta-analysis shows that thickened food is only moderately effective in treating gastroesophageal reflux in healthy infants.
目前,浓稠型喂养方式越来越多地被用于治疗胃食管反流的婴儿,这在很大程度上是受婴儿食品行业的推动。以往的荟萃分析表明,尽管浓稠型配方奶粉似乎并不能减少可测量的反流,但可能会减少呕吐。然而,由于数据有限,关于增稠剂的使用仍存在不确定性。
我们的目标是系统地评估和更新来自随机对照试验的数据,以了解浓稠型喂养方式治疗健康婴儿胃食管反流的疗效和安全性。
2008年5月检索了Cochrane图书馆、Medline、Embase和CINAHL数据库以及欧洲和北美儿科胃肠病学会议(自2000年起)的会议记录;从已审阅的文章中获取了其他参考文献。仅纳入评估用于婴儿治疗胃食管反流至少数天的浓稠型喂养方式的随机对照试验。三位审阅者使用标准数据提取表独立进行数据提取。审阅者之间的差异通过所有作者之间的讨论来解决。仅录入达成共识的数据。
纳入了14项采用平行或交叉设计的随机对照试验,其中一些试验存在方法学上的局限性。与标准配方奶粉相比,使用浓稠型配方奶粉显著增加了无反流婴儿的比例,略微减少了每天反流和呕吐的发作次数(联合评估或分别评估),并增加了每日体重增加;对反流指数、每小时酸性胃食管反流发作次数或持续时间>5分钟的反流发作次数没有影响,但显著缩短了pH<4的最长反流发作的持续时间。没有确切数据表明一种特定的增稠剂比另一种更有效。未观察到严重不良反应。
这项荟萃分析表明,浓稠型食物在治疗健康婴儿胃食管反流方面仅具有中等疗效。